You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 138 No. 10, October 1984 TABLE OF CONTENTS
  Archives
  •  Online Features
  ARTICLES
 This Article
 •References
 •Full text PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Continuous Naloxone Infusion in Pediatric Narcotic Overdose

James M. Lewis, MD; Wendy Klein-Schwartz, PharmD; Blaine E. Benson, PharmD; Gary M. Oderda, PharmD, MPH; Sandra Takai, MD

Am J Dis Child. 1984;138(10):944-946.


Abstract

• A 31-month-old girl required constant intravenous (IV) infusion of naloxone hydrochloride to treat codeineinduced respiratory and CNS depression. The infusion rate was 0.4 mg/hr (27 µg/kg/hr) over nine hours, without apparent side effects or evidence of toxic effects, for a total naloxone hydrochloride dose of 4.1 mg (280 µg/kg). Constant naloxone hydrochloride infusion at an initial rate of 0.4 mg/hr in pediatric narcotic poisoning should be considered if the patient responds inadequately to an initial 0.01-mg/kg bolus, requires repeated administration to reverse narcotic-induced effects, or has ingested long-acting agents. Continuous IV naloxone infusion is a convenient, safe, and effective method to treat narcotic overdose.

(AJDC 1984;138:944-946)



Author Affiliations

From the Departments of Pediatrics, University of Maryland School of Medicine (Dr Lewis) and Sinai Hospital of Baltimore (Dr Takai), and the Maryland Poison Center, University of Maryland School of Pharmacy (Drs Klein-Schwartz, Benson, and Oderda), Baltimore. Dr Lewis is now with the Marshall University School of Medicine, Huntington, WVa.


Footnotes

Reprint requests to Department of Pediatrics, Marshall University School of Medicine, 1801 Sixth Ave, Huntington, WV 25701 (Dr Lewis).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Adverse Effects in Children After Unintentional Buprenorphine Exposure
Geib et al.
Pediatrics 2006;118:1746-1751.
ABSTRACT | FULL TEXT  

Part 10.2: Toxicology in ECC
Circulation 2005;112:IV-126-IV-132.
FULL TEXT  

Adverse Effects Following the Inadvertent Administration of Opioids to Infants and Children
Meyer and Tobias
CLIN PEDIATR 2005;44:499-503.
ABSTRACT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1984 American Medical Association. All Rights Reserved.